Patients taking Tysabri report improvement in physical and psychological well-being over time
Sept. 11, 2009 - Biogen Idec and Elan Corporation, plc today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis patients taking TYSABRI experienced an improvement in both their physical function and psychological well-being. Findings from the study, which was ...
Join the discussion below, or Read more at EurekAlert!.
#1 Sep 12, 2009
Ahhhh Tysabri is SO good, 13 people with PML.
Screw the media and their advertisement that kills people.
Add your comments below
|Drugmaker Elan plans to explore sale of company (Jun '13)||Jun '13||HumanSpirit||1|
|Plavix deal stokes pharma stocks; Biogen, Elan ... (Apr '06)||May '13||Yadiel||5|
|IPO Preview: ChemoCentryx (May '12)||May '12||Robson||1|
|Biogen's MS drug in question (Jul '11)||Jul '11||gumby||1|
|Neuroimaging Technique Supports Reduction in Am... (Mar '10)||Mar '10||sophia brown||1|
|''Step Inside MS'' National Tour Brings First-o... (Sep '07)||Sep '07||Michelle||3|
Find what you want!
Search Elan Corporation Plc Forum Now
Copyright © 2016 Topix LLC